Koen Theunissen

't Hasselt, VLG, Belgium

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 27 publications

Pulmonary Artery Pressure Sensor-Guided Therapy for Cardiac AL Amyloidosis in a Young Multiple Myeloma Patient.

Pulmonary Artery Pressure Sensor-Guided Therapy for Cardiac AL Amyloidosis in a Young Multiple Myeloma Patient.

Journal: JACC. Case reports

Published: February 27, 2026

Real-world outcomes in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia or chronic myeloid leukemia treated with ponatinib - final 6-year results from a Belgian registry.

Real-world outcomes in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia or chronic myeloid leukemia treated with ponatinib - final 6-year results from a Belgian registry.

Journal: Hematology (Amsterdam, Netherlands)

Published: August 14, 2025

Daratumumab or Active Monitoring for High-Risk Smoldering Multiple Myeloma.

Daratumumab or Active Monitoring for High-Risk Smoldering Multiple Myeloma.

Journal: The New England journal of medicine

Published: December 09, 2024

Life 2.0: a comprehensive cross-sectional profiling of long-term allogeneic hematopoietic cell transplantation survivors compared to a matched general population cohort.

Life 2.0: a comprehensive cross-sectional profiling of long-term allogeneic hematopoietic cell transplantation survivors compared to a matched general population cohort.

Journal: Bone marrow transplantation

Published: July 16, 2024

Real-life data of luspatercept in lower-risk myelodysplastic syndromes advocate new research objectives.

Real-life data of luspatercept in lower-risk myelodysplastic syndromes advocate new research objectives.

Journal: EJHaem

Published: July 15, 2024

Real-world insights on the management of immune-mediated thrombotic thrombocytopenic purpura with caplacizumab.

Real-world insights on the management of immune-mediated thrombotic thrombocytopenic purpura with caplacizumab.

Journal: Blood vessels, thrombosis & hemostasis

Published: February 07, 2024

The Dynamics of Nucleotide Variants in the Progression from Low-Intermediate Myeloma Precursor Conditions to Multiple Myeloma: Studying Serial Samples with a Targeted Sequencing Approach.

The Dynamics of Nucleotide Variants in the Progression from Low-Intermediate Myeloma Precursor Conditions to Multiple Myeloma: Studying Serial Samples with a Targeted Sequencing Approach.

Journal: Cancers

Published: December 20, 2021

Acute autonomic dysregulation due to HHV-6 encephalitis in an immunocompromised patient: a case report and literature review.

Acute autonomic dysregulation due to HHV-6 encephalitis in an immunocompromised patient: a case report and literature review.

Journal: Acta neurologica Belgica

Published: August 12, 2021

Adjunctive Volasertib in Patients With Acute Myeloid Leukemia not Eligible for Standard Induction Therapy: A Randomized, Phase 3 Trial.

Adjunctive Volasertib in Patients With Acute Myeloid Leukemia not Eligible for Standard Induction Therapy: A Randomized, Phase 3 Trial.

Journal: HemaSphere

Published: December 15, 2020

Clinical outcomes in patients with Philadelphia chromosome-positive leukemia treated with ponatinib in routine clinical practice-data from a Belgian registry.

Clinical outcomes in patients with Philadelphia chromosome-positive leukemia treated with ponatinib in routine clinical practice-data from a Belgian registry.

Journal: Annals of hematology

Published: July 28, 2020

Recombinant Zoster Vaccine Significantly Reduces the Impact on Quality of Life Caused by Herpes Zoster in Adult Autologous Hematopoietic Stem Cell Transplant Recipients: A Randomized Placebo-Controlled Trial (ZOE-HSCT).

Recombinant Zoster Vaccine Significantly Reduces the Impact on Quality of Life Caused by Herpes Zoster in Adult Autologous Hematopoietic Stem Cell Transplant Recipients: A Randomized Placebo-Controlled Trial (ZOE-HSCT).

Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation

Published: June 17, 2019

Providing both autologous and allogeneic hematopoietic stem cell transplants (HSCT) may have a stronger impact on the outcome of autologous HSCT in adult patients than activity levels or implementation of JACIE at Belgian transplant centres.

Providing both autologous and allogeneic hematopoietic stem cell transplants (HSCT) may have a stronger impact on the outcome of autologous HSCT in adult patients than activity levels or implementation of JACIE at Belgian transplant centres.

Journal: Bone marrow transplantation

Published: August 03, 2018

Showing 1-12 of 27

Last Updated: 09/26/2026